Skip to Content
MilliporeSigma
All Photos(1)

Documents

T1978000

Tricaprylin

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Glyceryl trioctanoate, 1,2,3-Tricapryloylglycerol, 1,2,3-Trioctanoylglycerol, Glycerol tricaprylate, Glycerol trioctanoate, Glyceryl tricaprylate, Tricaprylin, Trioctanoin

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
[CH3(CH2)6COOCH2]2CHOCO(CH2)6CH3
CAS Number:
538-23-8
Molecular Weight:
470.68
Beilstein/REAXYS Number:
1717202
MDL number:
MFCD00036236
UNSPSC Code:
41116107
PubChem Substance ID:
329826698
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

tricaprylin

manufacturer/tradename

EDQM

bp

233 °C/1 mmHg (lit.)

density

0.956 g/mL at 20 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

−20°C

SMILES string

CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC

InChI

1S/C27H50O6/c1-4-7-10-13-16-19-25(28)31-22-24(33-27(30)21-18-15-12-9-6-3)23-32-26(29)20-17-14-11-8-5-2/h24H,4-23H2,1-3H3

InChI key

VLPFTAMPNXLGLX-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Tricaprylin EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Storage Class

10 - Combustible liquids

wgk_germany

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 6

1 of 6

vibrant-m

Y0000794

Glycerol monocaprylate

Triolein European Pharmacopoeia (EP) Reference Standard

Y0001113

Triolein

Supelco

Supelco

17810

Triglyceride Mix

Trimyristin European Pharmacopoeia (EP) Reference Standard

T2500100

Trimyristin

Supelco

Supelco

17811-1AMP

Lipid standards: triglyceride mixtures

Glyceryl tristearate ≥99%

Sigma-Aldrich

T5016

Glyceryl tristearate

Ken-Ichi Ogawara et al.
Journal of pharmaceutical sciences, 106(4), 1143-1148 (2017-01-09)
To develop a safer and more potent paclitaxel (PTX) formulation, we prepared various oil-in-water emulsions by using egg phosphatidylcholine, Tween 80, and a mixture of triglycerides with different fatty acid chain lengths as the cosurfactant, surfactant, and oil phase component
Sung Yong Lee et al.
Journal of biomedical science, 26(1), 41-41 (2019-05-28)
Endoplasmic reticulum stress has a profound effect on cancer cell proliferation and survival, and also has the capacity to activate cells of the adaptive immune system. Multimodal treatment methods that utilize and combine conventional cancer therapies with antigen-specific immunotherapies have
Li Huang et al.
Experimental animals, 68(3), 301-306 (2019-03-15)
Inflammation-related animal model is necessary to better understanding the association of inflammation with tumorigenesis. Although mouse models of inflammation-related lung tumorigenesis on A/J mice strain have been set up in previous study, there is no report on the model on
Ada W Y Leung et al.
Pharmaceutics, 11(3) (2019-03-20)
Liposomes are considered one of the most successful drug delivery systems (DDS) given their established utility and success in the clinic. In the past 40⁻50 years, Canadian scientists have made ground-breaking discoveries, many of which were successfully translated to the
Qi Zhang et al.
Oncotarget, 8(42), 72447-72456 (2017-10-27)
Gefitinib showed response in phase II clinical trials and with better clinical response in lung cancer with activating mutations in the tyrosine kinase domain of the EGFR. Questions of toxicity and potential dosing regimens impede the use in a prevention
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service